Re: Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer

被引：14
|
作者：
Drake, Charles G. [1 ]
机构：
[1] Johns Hopkins Univ, Dept Oncol, Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2012年 / 104卷 / 18期
关键词：
HOMEOSTATIC PROLIFERATION; CELLS; REJECTION; MELANOMA;
D O I：
10.1093/jnci/djs340
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1422 / 1422
页数：1
相关论文
共 50 条
  • [21] Metformin and Prostate Cancer: Reduced Development of Castration-resistant Disease and Prostate Cancer Mortality
    Spratt, Daniel E.
    Zhang, Chi
    Zumsteg, Zachary S.
    Pei, Xin
    Zhang, Zhigang
    Zelefsky, Michael J.
    EUROPEAN UROLOGY, 2013, 63 (04) : 709 - 716
  • [22] Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer
    Gardner, Thomas A.
    Elzey, Bennett D.
    Hahn, Noah M.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (04) : 534 - 539
  • [23] Interferon-γ increases sensitivity to chemotherapy and provides immunotherapy targets in models of metastatic castration-resistant prostate cancer
    Korentzelos, Dimitrios
    Wells, Alan
    Clark, Amanda M.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [24] MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer
    Bhagirath, Divya
    Liston, Michael
    Patel, Nikhil
    Akoto, Theresa
    Lui, Byron
    Yang, Thao Ly
    To, Dat My
    Majid, Shahana
    Dahiya, Rajvir
    Tabatabai, Z. Laura
    Saini, Sharanjot
    ONCOGENE, 2020, 39 (49) : 7209 - 7223
  • [25] Improving Taxane-Based Chemotherapy in Castration-Resistant Prostate Cancer
    Kroon, Jan
    Kooijman, Sander
    Cho, Nam-Joon
    Storm, Gert
    van der Pluijm, Gabri
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2016, 37 (06) : 451 - 462
  • [26] Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylin
    Zheng, Jianwei
    Wang, Junfeng
    Wang, Qian
    Zou, Hongye
    Wang, Hong
    Zhang, Zhenhua
    Chen, Jianghe
    Wang, Qianqian
    Wang, Panxia
    Zhao, Yueshan
    Lu, Jing
    Zhang, Xiaolei
    Xiang, Songtao
    Wang, Haibin
    Lei, Jinping
    Chen, Hong-Wu
    Liu, Peiqing
    Liu, Yonghong
    Han, Fanghai
    Wang, Junjian
    ACTA PHARMACEUTICA SINICA B, 2020, 10 (12) : 2313 - 2322
  • [27] Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity
    Cherif, Chaima
    Nguyen, Dang Tan
    Paris, Clement
    Le, Thi Khanh
    Sefiane, Thibaud
    Carbuccia, Nadine
    Finetti, Pascal
    Chaffanet, Max
    El Kaoutari, Abdessamad
    Vernerey, Julien
    Fazli, Ladan
    Gleave, Martin
    Manai, Mohamed
    Barthelemy, Philippe
    Birnbaum, Daniel
    Bertucci, Francois
    Taieb, David
    Rocchi, Palma
    ONCOGENE, 2022, 41 (01) : 125 - 137
  • [28] HE3235 Inhibits Growth of Castration-Resistant Prostate Cancer
    Koreckij, Theodore D.
    Trauger, Richard J.
    Montgomery, Robert Bruce
    Pitts, Tiffany E. M.
    Coleman, Ilsa
    Nguyen, Holly
    Reading, Chris L.
    Nelson, Peter S.
    Vessella, Robert L.
    Corey, Eva
    NEOPLASIA, 2009, 11 (11): : 1216 - U136
  • [29] Synthesis of novel tanshinone derivatives for treatment of castration-resistant prostate cancer
    Xu, Defeng
    Hu, Hang
    Guan, Jing
    Da, Jun
    Xie, Yipeng
    Liu, Yalin
    Kong, Ren
    Song, Guoqiang
    Zhou, Huan
    CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 94 (03) : 1656 - 1663
  • [30] Gli2 mediates the development of castration-resistant prostate cancer
    Xia, Lu
    Bouamar, Hakim
    Gu, Xiang
    Zeballos, Carla
    Qin, Tai
    Wang, Bingzhi
    Zhou, You
    Wang, Yuhui
    Yang, Junhua
    Zhu, Haiyan
    Zhang, Weishe
    Houghton, Peter J.
    Sun, Lu-Zhe
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 57 (01) : 100 - 112
12345